Purdue Pharma

OxyContin Maker's Bankruptcy Deal Goes Before The Supreme Court

The justices seemed by turns reluctant to break up an exhaustively negotiated agreement, but also leery of somehow rewarding the Sacklers.
By Mark Sherman, AP

Supreme Court Blocks Purdue Pharma Deal That Shields Sackler Family

The OxyContin manufacturer has long been accused of ignoring the drug's addictive qualities in favor of profit.
By 

Trevor Project Ousts CEO Who Played A Role In The Opioid Crisis

HuffPost previously revealed that Amit Paley was part of a McKinsey consulting team for notorious OxyContin maker Purdue Pharma.
By 

How The CEO Of A Leading LGBTQ Rights Group Played A Role During The Opioid Crisis

Amit Paley, CEO of The Trevor Project, was part of a team advising Purdue Pharma on how to boost sales of opioids during his time at McKinsey & Co., according to a trove of documents reviewed by HuffPost.
By 

'You Are Scum Of The Earth': Opioid Crisis Victims Testify Before Sackler Family

In three hours of emotional testimony, over two dozen people were able to directly confront the Purdue Pharma owners about the human toll of the crisis.
By 

Opioid Crisis Victims To Confront Purdue Pharma’s Owners In Hearing

Roughly 20 people whose lives and families have been wracked by opioid abuse will give statements in U.S. Bankruptcy Court with some Sackler family members listening.
By AP

Purdue Pharma, US States Agree To New Opioid Settlement

States agreed to sign on after the Sacklers kicked in more cash and accepted other terms, including apologizing.
By Geoff Mulvihill and John Seewer, AP

Federal Judge Overturns Purdue Pharma Settlement That Left Sacklers Protected From Suits

“This is a seismic victory for justice and accountability that will re-open the deeply flawed Purdue bankruptcy," Connecticut's attorney general said.
By 

Judge Tentatively OKs Purdue Pharma Deal In Opioid Cases

The Sackler family will give up ownership of the company and contribute $4.5 billion but will be freed from any future lawsuits over opioids.
By By GEOFF MULVIHILL, AP

Judge Set To Rule On Purdue Pharma's Opioid Settlement Plan

A U.S. bankruptcy judge is expected to rule on whether the OxyContin maker will settle thousands of lawsuits.
By GEOFF MULVIHILL, AP